Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q1

7459.TEDINET S100RN8E
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥886.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥3.36T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥838.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥12.4bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥13.5bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥16.7bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥65.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥17.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥20.0bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥17.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥11.2bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥38.8bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥8.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥13.9bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥10.8bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥1.78Tat 2023-06-30Cons.Assets
Total assets¥1.71Tat 2023-03-31Cons.Assets
Total assets¥1.72Tat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥1.07Tat 2023-06-30Cons.Liabilities
Total liabilities¥1.02Tat 2023-03-31Cons.Liabilities
Net assets / equity¥710.1bnat 2023-06-30Cons.Net assets
Net assets / equity¥688.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥659.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥200.2bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥195.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥52.322023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.822022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥39.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥179.122022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.942022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio32.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio32.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥903m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥903m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥49m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥28.9bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥28.9bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥0
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥831m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥293.5bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥293.4bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥74m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥7.0bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥565.2bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥564.4bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥828m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥887.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥886.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥903m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥12.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30¥98m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥692m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥94m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.5bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥544.4bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥543.6bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥817m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥839.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥838.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥913m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥13.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 380
ItemContextValueUnit
Salaries and allowances sgaCurrentYTDDuration17281000000JPY
Welfare expenses sgaPrior1YTDDuration2977000000JPY
Welfare expenses sgaCurrentYTDDuration3367000000JPY
Provision for bonuses sgaPrior1YTDDuration2406000000JPY
Provision for bonuses sgaCurrentYTDDuration3483000000JPY
Retirement benefit expenses sgaPrior1YTDDuration757000000JPY
Retirement benefit expenses sgaCurrentYTDDuration978000000JPY
Distribution expenses sgaPrior1YTDDuration4745000000JPY
Distribution expenses sgaCurrentYTDDuration4889000000JPY
Rents sgaPrior1YTDDuration1025000000JPY
Rents sgaCurrentYTDDuration1195000000JPY
Depreciation sgaPrior1YTDDuration3030000000JPY
Depreciation sgaCurrentYTDDuration3307000000JPY
Other sgaPrior1YTDDuration11429000000JPY
Other sgaCurrentYTDDuration12431000000JPY
Selling general and administrative expensesPrior1YTDDuration42509000000JPY
Selling general and administrative expensesCurrentYTDDuration46935000000JPY
Operating incomePrior1YTDDuration13516000000JPY
Operating incomeCurrentYTDDuration12401000000JPY
Interest income noiPrior1YTDDuration41000000JPY
Interest income noiCurrentYTDDuration3000000JPY
Dividends income noiPrior1YTDDuration837000000JPY
Dividends income noiCurrentYTDDuration852000000JPY
Research fee income noiPrior1YTDDuration2077000000JPY
Research fee income noiCurrentYTDDuration2224000000JPY
Real estate rent noiPrior1YTDDuration495000000JPY
Real estate rent noiCurrentYTDDuration536000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration600000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration701000000JPY
Other noiPrior1YTDDuration276000000JPY
Other noiCurrentYTDDuration326000000JPY
Non operating incomePrior1YTDDuration4329000000JPY
Non operating incomeCurrentYTDDuration4646000000JPY
Interest expenses noePrior1YTDDuration3000000JPY
Interest expenses noeCurrentYTDDuration2000000JPY
Rent expenses on real estates noePrior1YTDDuration234000000JPY
Rent expenses on real estates noeCurrentYTDDuration278000000JPY
Other noePrior1YTDDuration21000000JPY
Other noeCurrentYTDDuration90000000JPY
Non operating expensesPrior1YTDDuration259000000JPY
Non operating expensesCurrentYTDDuration371000000JPY
Ordinary incomePrior1YTDDuration17586000000JPY
Ordinary incomeCurrentYTDDuration16676000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration－JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Gain on step acquisitions eiPrior1YTDDuration－JPY
Gain on step acquisitions eiCurrentYTDDuration1253000000JPY
Gain on sales of investment securities eiPrior1YTDDuration3442000000JPY
Gain on sales of investment securities eiCurrentYTDDuration140000000JPY
Compensation income eiPrior1YTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass